Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneurons

J Neurophysiol. 2000 Jan;83(1):322-32. doi: 10.1152/jn.2000.83.1.322.

Abstract

Adenosine is a potent regulator of acetylcholine release in the striatum, yet the mechanisms mediating this regulation are largely undefined. To begin to fill this gap, adenosine receptor expression and coupling to voltage-dependent Ca(2+) channels were studied in cholinergic interneurons by combined whole cell voltage-clamp recording and single-cell reverse transcription-polymerase chain reaction. Cholinergic interneurons were identified by the presence of choline acetyltransferase mRNA. Nearly all of these interneurons (90%, n = 28) expressed detectable levels of A(1) adenosine receptor mRNA. A(2a) and A(2b) receptor mRNAs were less frequently detected. A(3) receptor mRNA was undetectable. Adenosine rapidly and reversibly reduced N-type Ca(2+) currents in cholinergic interneurons. The A(1) receptor antagonist 8-cyclopentyl-1, 3-dimethylxanthine completely blocked the effect of adenosine. The IC(50) of the A(1) receptor selective agonist 2-chloro-N6-cyclopentyladenosine was 45 nM, whereas it was near 30 microM for the A(2a) receptor agonist CGS-21680. Dialysis with GDPbetaS or brief exposure to the G protein (G(i/o)) alkylating agent N-ethylmaleimide also blocked the adenosine modulation. The reduction in N-type currents was partially reversed by depolarizing prepulses. A membrane-delimited pathway mediated the modulation, because it was not seen in cell-attached patches when agonist was applied to the bath. Activation of protein kinase C attenuated the adenosine modulation. Taken together, our results argue that activation of A(1) adenosine receptors in cholinergic interneurons reduces N-type Ca(2+) currents via a membrane-delimited, G(i/o) class G-protein pathway that is regulated by protein kinase C. These observations establish a cellular mechanism by which adenosine may serve to reduce acetylcholine release.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Animals
  • Calcium Channels, N-Type / drug effects
  • Calcium Channels, N-Type / physiology*
  • Choline O-Acetyltransferase / genetics
  • Corpus Striatum / physiology*
  • Ethylmaleimide / pharmacology
  • GTP-Binding Proteins / metabolism
  • Guanosine Diphosphate / analogs & derivatives
  • Guanosine Diphosphate / pharmacology
  • In Vitro Techniques
  • Interneurons / drug effects
  • Interneurons / physiology*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Patch-Clamp Techniques
  • Phenethylamines / pharmacology
  • RNA, Messenger / analysis
  • Rats
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / genetics*
  • Receptors, Purinergic P1 / physiology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Theophylline / analogs & derivatives
  • Theophylline / pharmacology
  • Thionucleotides / pharmacology

Substances

  • Calcium Channels, N-Type
  • Phenethylamines
  • RNA, Messenger
  • Receptors, Purinergic P1
  • Thionucleotides
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • Guanosine Diphosphate
  • 8-cyclopentyl-1,3-dimethylxanthine
  • 2-chloro-N(6)cyclopentyladenosine
  • guanosine 5'-O-(2-thiodiphosphate)
  • Theophylline
  • Choline O-Acetyltransferase
  • GTP-Binding Proteins
  • Adenosine
  • Ethylmaleimide